0001609351-19-000015.txt : 20190117 0001609351-19-000015.hdr.sgml : 20190117 20190117214550 ACCESSION NUMBER: 0001609351-19-000015 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190115 FILED AS OF DATE: 20190117 DATE AS OF CHANGE: 20190117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mingozzi Federico CENTRAL INDEX KEY: 0001732126 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36819 FILM NUMBER: 19532073 MAIL ADDRESS: STREET 1: 3737 MARKET STREET, SUITE 1300 CITY: PHILADELPHIA STATE: PA ZIP: 19104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Spark Therapeutics, Inc. CENTRAL INDEX KEY: 0001609351 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 462654405 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3737 MARKET STREET STREET 2: SUITE 1300 CITY: PHILADELPHIA STATE: PA ZIP: 19104 BUSINESS PHONE: 888-772-7560 MAIL ADDRESS: STREET 1: 3737 MARKET STREET STREET 2: SUITE 1300 CITY: PHILADELPHIA STATE: PA ZIP: 19104 4 1 wf-form4_154777953365482.xml FORM 4 X0306 4 2019-01-15 0 0001609351 Spark Therapeutics, Inc. ONCE 0001732126 Mingozzi Federico 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104 0 1 0 0 Chief Scientific Officer Employee Stock Option (right to buy) 42.73 2019-01-15 4 A 0 35000 0 A 2029-01-15 Common Stock 35000.0 35000 D Restricted Stock Units 2019-01-15 4 A 0 10000 0 A Common Stock 10000.0 10000 D 25% vests January 15, 2020 and the remainder vests in equal annual installments over the following three years. Each restricted stock unit represents a contingent right to receive one share of Spark Therapeutics, Inc. common stock. The restricted stock units vest in four equal annual installments beginning January 15, 2020. Vested shares will be delivered to the reporting person annually on the vesting date. /s/ Joseph W. La Barge, attorney-in-fact for Federico Mingozzi 2019-01-17